Moleculight i:X™早期识别左心室辅助装置驱动线感染的前瞻性评估
本研究在门诊前瞻性纳入107例次疑似驱动线感染(DLI)检查,评估手持荧光成像设备Moleculight i:X™的诊断表现。结果显示该设备敏感性13.51%、特异性72.73%,阳性预测值52.63%、阴性预测值27.27%,作者认为其敏感性与特异性均低,临床检查与拭子培养仍应作为金标准。
要点
- Moleculight i:X™诊断驱动线感染敏感性仅13.51%,易漏诊。
- 特异性72.73%,阳性预测值52.63%,阴性预测值27.27%。
- 临床检查加拭子培养仍是驱动线感染诊断金标准。
核心结论
- Moleculight i:X™在门诊检测驱动线感染时敏感性与特异性均低,尚不能替代临床检查与微生物学检查。
研究设计与样本
- 前瞻性研究,共纳入107例次疑似驱动线感染患者的门诊检查,荧光图像与拭子由伤口专家和两名心外科医生独立于微生物结果判读。
主要发现
- Moleculight i:X™红色荧光阳性19例(17.76%),微生物学检查阳性74例(69.16%)。
- 最常见细菌为金黄色葡萄球菌。
- 诊断敏感性13.51%、特异性72.73%,阳性预测值52.63%、阴性预测值27.27%。
- 按不同伤口敷料或既往抗生素治疗进行亚组分析未见相关差异。
关键数值与推荐
- 敏感性13.51%,特异性72.73%,阳性预测值52.63%,阴性预测值27.27%。
- 微生物学阳性74例(69.16%),荧光阳性19例(17.76%)。
临床怎么用
- 门诊怀疑驱动线感染时应继续以临床检查与拭子培养为标准,不应仅凭该荧光设备排除感染。
局限性
- 外科翻修驱动线后开放伤口的敏感性与特异性尚待明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Driveline infection (DLI) is a common complication in patients with left ventricular assist devices. This complication can seriously undermine quality of life while on left ventricular assist devices. Current diagnosis of a DLI in the outpatient setting is based on clinical examination and later bacteria isolation. The Moleculight i:XTM is a handheld fluorescence imaging device capable to visualize bacterial colonization in real-time. We here evaluated the performance of the Moleculight i:XTM for diagnosis of DLIs as this device may have the potential advantage to rapidly identify infection and therefore promptly influence therapy. METHODS: A total of 107 examinations in patients with suspected DLIs were prospectively included in this study. All examinations took place in the outpatient setting. In addition to the standard treatment, Moleculight fluorescence images were captured and swabs were taken at the area of maximal luminosity. Wounds and pictures were reviewed and classified as positive or negative by a wound specialist and two heart surgeons independently from microbiological results. RESULTS: The Moleculight i:XTM showed positive results (red fluorescence) in 19 cases (17.76%), whereas microbiological examination was positive for microorganisms in 74 cases (69.16%). The most common bacteria was Staphylococcus aureus. The findings resulted in a sensitivity of 13.51% and a specificity of 72.73%. The positive predictive value was 52.63% and the negative predictive value was 27.27%. Sub-analyses of different wound dressings or previous antibiotic treatment did not show any relevant difference. CONCLUSIONS: The results of the Moleculight i:X show a low sensitivity and specificity when being used to detect DLIs in the outpatient setting. Clinical examination and swabs should remain the gold standard despite the delay for bacteria isolation and consequent antibiotic treatment. Sensitivity and specificity of the Moleculight i:X in open wounds after surgical revision of the driveline remain to be clarified.
引用
- Olbrich A, Motekallemi A, Deschka H, et al. Prospective evaluation of the Moleculight i:X™ in the early detection of driveline infections. Interdiscip Cardiovasc Thorac Surg. 2025. PMID: 40152260. doi:10.1093/icvts/ivae215
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。